TY - JOUR
T1 - Comparison of the Japan Society of Clinical Chemistry reference method and CDC method for HDL and LDL cholesterol measurements using fresh sera
AU - Kayamori, Yuzo
AU - Nakamura, Masakazu
AU - Kishi, Koji
AU - Miida, Takashi
AU - Nishimura, Kunihiro
AU - Okamura, Tomonori
AU - Hirayama, Satoshi
AU - Ohmura, Hirotoshi
AU - Yoshida, Hiroshi
AU - Ai, Masumi
AU - Tanaka, Akira
AU - Sumino, Hiroyuki
AU - Murakami, Masami
AU - Inoue, Ikuo
AU - Teramoto, Tamio
AU - Yokoyama, Shinji
N1 - Funding Information:
We thank Ikunosuke Sakurabayashi (Jichi Medical School) and Tsutomu Nobori (Oyamada Memorial Spa Hospital) for their technical advice. We thank Miyuki Sakemoto and Keiko Fujino for their excellent technical assistance. We thank all the subjects for participating in this study.
Publisher Copyright:
© 2021 The Author(s)
PY - 2021/5
Y1 - 2021/5
N2 - Objectives: In 2009, the Japan Society of Clinical Chemistry (JSCC) recommended a reference method for the measurement of serum high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels. This automated method uses cholesterol esterase-cholesterol dehydrogenase to measure cholesterol levels in fractions obtained after ultracentrifugation and dextran sulfate/magnesium chloride precipitation. In the present study, using fresh samples, we compared the LDL-C and HDL-C levels measured using this method with those measured using the traditional Centers for Disease Control and Prevention (CDC)-beta-quantification (BQ) method. Design: and methods: Using both the JSCC and CDC-BQ methods, LDL-C/HDL-C levels were measured in 47 non-diseased and 126 diseased subjects, whose triglyceride levels were lower than 11.29 mmol/L (1000 mg/dL). Results: For LDL-C, the equation of the line representing the correlation between the two methods was y = 0.991x + 0.009 mmol/L; r = 0.999; and Sy/x = 0.025 mmol/L, where x is the mean LDL-C level measured using the CDC-BQ method. Similarly, for HDL-C, the equation of the line representing the correlation between the two methods was y = 0.988x + 0.041 mmol/L, r = 0.999, and Sy/x = 0.019 mmol/L, where x is the mean HDL-C level measured using the CDC-BQ method. Conclusions: The JSCC method agreed with the CDC-BQ method in cases of both non-diseased and diseased subjects, including those with dyslipidemia.
AB - Objectives: In 2009, the Japan Society of Clinical Chemistry (JSCC) recommended a reference method for the measurement of serum high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels. This automated method uses cholesterol esterase-cholesterol dehydrogenase to measure cholesterol levels in fractions obtained after ultracentrifugation and dextran sulfate/magnesium chloride precipitation. In the present study, using fresh samples, we compared the LDL-C and HDL-C levels measured using this method with those measured using the traditional Centers for Disease Control and Prevention (CDC)-beta-quantification (BQ) method. Design: and methods: Using both the JSCC and CDC-BQ methods, LDL-C/HDL-C levels were measured in 47 non-diseased and 126 diseased subjects, whose triglyceride levels were lower than 11.29 mmol/L (1000 mg/dL). Results: For LDL-C, the equation of the line representing the correlation between the two methods was y = 0.991x + 0.009 mmol/L; r = 0.999; and Sy/x = 0.025 mmol/L, where x is the mean LDL-C level measured using the CDC-BQ method. Similarly, for HDL-C, the equation of the line representing the correlation between the two methods was y = 0.988x + 0.041 mmol/L, r = 0.999, and Sy/x = 0.019 mmol/L, where x is the mean HDL-C level measured using the CDC-BQ method. Conclusions: The JSCC method agreed with the CDC-BQ method in cases of both non-diseased and diseased subjects, including those with dyslipidemia.
KW - Beta-quantification
KW - Cholesterol dehydrogenase
KW - HDL-cholesterol
KW - Homogeneous assay
KW - LDL-cholesterol
KW - Reference method
UR - http://www.scopus.com/inward/record.url?scp=85105010241&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105010241&partnerID=8YFLogxK
U2 - 10.1016/j.plabm.2021.e00228
DO - 10.1016/j.plabm.2021.e00228
M3 - Article
AN - SCOPUS:85105010241
SN - 2352-5517
VL - 25
JO - Practical Laboratory Medicine
JF - Practical Laboratory Medicine
M1 - e00228
ER -